SEC Sues Microcap Company Over Coronavirus Test Kit Misrepresentations
NEW YORK — A microcap company misrepresented to investors that it had shifted its business from production of cannabinoid-based products to products used to battle the novel coronavirus, including a home...To view the full article, register now.
Already a subscriber? Click here to view full article